Compugen's innovative approach targets under-explored immune pathways like PVRIG and IL-18 binding protein. Read why I'm ...

A recent study led by Associate Professor Takuya Yamamoto and Researcher May Nakajima-Koyama has revealed that maintaining a delicate balance between interferon-gamma (IFN-γ) and extracellular ...

Despite the established links between inflammation and cancer development, the effects of inflammatory signaling on cancer ...

A study led by a team of researchers at the University of Kentucky's Martin-Gatton College of Agriculture, Food and ...

A groundbreaking study has revealed a surprising biochemical connection between plant immune responses and human neurological health. Researchers have discovered that the metabolic pathways regulating ...

A newly identified part of a brain circuit mixes sensory information, memories, and emotions to tell whether things are familiar or new, and important or just 'background noise.' ...

The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...

scientific understanding of the anti-TIGIT pathway and new avenues in cancer research.” Roche has another half-dozen phase 3 trials on the go with tiragolumab in other NSCLC settings ...

By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...

At the time, Barron said that combinations of a PD-1 with TIGIT, CD96 and PVRIG inhibitors – the latter three all acting around the CD226 pathway – could become transformative medicines for ...

The influenza A virus genome consists of eight segments of single-stranded, negative-sense viral RNA, which encode multiple ...

Filled with the top stories to start your day, and emergency news alerts.